Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Javelin Pharmaceuticals
The primary objective is to evaluate platelet function following intravenous diclofenac, oral diclofenac (Cataflam), intravenous ketorolac and oral aspirin.
Age
18–55
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Healthy male subjects.
Willing and able to stay at the clinical site for approximately 8 nights over 9 days and to return to the clinic approximately 7 days after discharge.
You may not be if
Bleeding abnormalities or cardiovascular events.
Known allergy or hypersensitivity to the active compounds or any of the excipients used in the study.
